VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases. - Archive ouverte HAL Access content directly
Journal Articles Thrombosis Research Year : 2007

VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.

(1) , (1) , (1) , (2) , (3) , (1) , (1, 3)
1
2
3

Abstract

Proteolysis of fibrin matrices by endothelial cells plays essential roles in the migratory and morphogenic differentiation processes underlying angiogenesis. Using an in vitro fibrinolysis model consisting of human umbilical vein endothelial cells (HUVECs) embedded in a three dimensional fibrin matrix, we show that VEGF, an angiogenic cytokine that plays a crucial role in the onset of angiogenesis, is a potent activator of HUVEC-mediated fibrinolysis. This VEGF-dependent fibrin degradation was completely abrogated by inhibitors of either the plasminogen activator/plasmin or matrix metalloproteinases (MMP) proteolytic systems, suggesting the involvement of both classes of proteases in fibrin degradation. Accordingly, VEGF-induced fibrinolysis correlated with an increase in the expression of tPA and of some MMPs, such as MT2-MMP and was completely blocked by a neutralizing antibody against tPA. Overall, these results indicate that efficient proteolysis of three dimensional fibrin matrices during VEGF-mediated angiogenesis involves a complex interplay between the MMP and plasmin-mediated proteolytic systems.
Fichier principal
Vignette du fichier
29F16A2Ed01.pdf (1.13 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00383800 , version 1 (03-07-2009)

Identifiers

Cite

David Ratel, Samira Mihoubi, Edith Beaulieu, Yves Durocher, Georges-Etienne Rivard, et al.. VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.. Thrombosis Research, 2007, 121 (2), pp.203-12. ⟨10.1016/j.thromres.2007.03.024⟩. ⟨inserm-00383800⟩

Collections

INSERM U836
204 View
472 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More